Sofia, Bulgaria, July 7, 2020 „Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that the text „art. 111, para. 8 of LPOS“, should be replaced with the text „art.

Sofia, Bulgaria, July 6, 2020 – “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for June 2020 the Company recorded a decrease in sales of 5% compared to the same month of 2019, incl. 78% decrease in domestic sales and 59% increase in export sales.

In the first half of 2020 the revenues from sales of production increase by 1% compared to the same period of 2019, incl. 19% decrease of sales for the domestic market and 13% increase in export sales.

Sofia, Bulgaria, July 1, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 30, 2020 the Company sold 12 000 own shares representing 0.0089% of the share capital of the Company, at a total value of BGN 37 950 on the Bulgarian Stock Exchange, the average price per share was 3.1625 BGN.

The total number of treasury shares after this transaction is 8 974 467, representing 6.658% of the share capital of the Company.

Sofia, Bulgaria, June 30, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 29, 2020 the Company sold 42 000 own shares representing 0.0312% of the share capital of the Company, at a total value of BGN 132 300 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.

The total number of treasury shares after this transaction is 8 986 467, representing 6.667% of the share capital of the Company.